News Agencies Feed 

HEALTHCARE

How Saudi Arabia is leading Middle East’s fight against breast cancer
October 17, 2019

ABU DHABI: Cancer of the breast remains the most common form of the disease among women despite major advances in treatment coupled with improved screening and awareness campaigns.

Rates of the disease are increasing in nearly every region globally as aging populations and factors such as obesity take their toll.

In"...

Continue Reading >

Johns Hopkins Center for Health Security, World Economic Forum and Bill & Melinda Gates Foundation Host Pandemic Exercise and Livestream
October 17, 2019

The Johns Hopkins Center for Health Security, with the World Economic Forum and the Bill & Melinda Gates Foundation, will host Event 201, a multimedia global pandemic exercise on Friday, Oct. 18, 2019, in New York City. The public may register and participate in the simultaneous virtual exercise in English, 8:50 a.m.-12:30 p.m. EDT at centerforhealthsecurity.org/event201/. The exercise underscores the need for global public-private cooperation to mitigate economic and societal impacts of severe pandemics. In recent years, the world has seen a growing number of epidemic events, about 200 per year, which strain limited resources. A large global pandemic would be disruptive to health, economies, and society. Economic studies show that pandemics could be the cause of an average annual economic loss of......

Continue Reading >

Boehringer Ingelheim Announces First Patient Enrolled in Phase II Trial of Novel Cystic Fibrosis Treatment (BALANCE-CFTM 1)
October 16, 2019

Boehringer Ingelheim today announced the first patient enrolled in its Phase II clinical trial BALANCE-CFTM 1 to evaluate a new potential treatment for cystic fibrosis.1,2 The trial will investigate how different doses of the compound, an inhaled epithelial sodium channel (ENaC) inhibitor, impact lung function compared to placebo when added to the standard of care in adults and adolescents with cystic fibrosis.1,3,4

People"...

Continue Reading >

Accomplishments of Dr. Steven Rosenberg in Cancer Immunotherapy Inspire Young Researchers in Japan & XIV Fujio Cup Quiz on Stem Cells Is Won by India.
October 16, 2019

Utilizing the capability of one’s own immune system to tackle cancer, an out-of-the box idea was the brain child of Dr. Steven Rosenberg almost three decades ago. His initiative which paved way for a new chapter in oncology, inspired many young scientists and clinicians in the NCRM NICHE 2019 held in Tokyo, Japan, as his acceptance speech in the Edogawa NICHE Prize ceremony was videocast.

NCRM"...

Continue Reading >

Regional clinical lab market worth $10bn, say experts
October 15, 2019

The region’s clinical laboratory services market is estimated to be worth around $8 - $10 billion growing at a CAGR of 6 per cent - 8 per cent until 2025, said the organisers of the upcoming Saudi Laboratory Congress in Jeddah, citing a Colliers International report.

The 2019 Saudi Laboratory and Diagnostics Congress will kick off tomorrow (October 13) placing prominence on the latest advancements and international guidelines in the medical laboratory"...

Continue Reading >

Takeda Agrees to Divest Select OTC and Non-core Assets to Acino for Over $200 Million USD
October 15, 2019

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select over-the-counter (OTC) and prescription pharmaceutical assets in a number of Near East, Middle East and Africa (NEMEA) countries within its Growth and Emerging Markets Business Unit to Acino for a total value in excess of $200 million USD. This is the third transaction in FY19 that furthers Takeda’s"...

Continue Reading >

Analysis of Patients With Prior Gastrectomy Treated With LONSURF® (trifluridine/tipiracil) Published in JAMA Oncology
October 14, 2019

Servier and its partner Taiho Oncology, Inc. (US), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), announced today that detailed results from the analysis of patients with prior gastrectomy enrolled in the Phase III TAS-102 Gastric Study (TAGS) evaluating LONSURF® (trifluridine/tipiracil) in adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma previously treated with at least two prior lines of chemotherapy that included"...

Continue Reading >

Fakih IVF Supports Breast Cancer Awareness Month
October 13, 2019

In support of the Breast Cancer Awareness Month, Fakih IVF Fertility Center seeks to reach out to all women battling the disease by helping preserve their fertility and fulfill their dream of starting a family.

Throughout the month of October, the fertility center is running a “Together We Are Stronger” campaign, to honor these patients and strive hard to help them so that cancer"...

Continue Reading >

IJPP features Nahdi’s Diabetes Research Paperabia
October 10, 2019

JEDDAH — For the first time in the United Kingdom, the IJPP (International Journal of Pharmacy Practice) featured Nahdi’s Diabetes Research Paper. Al Nahdi is the first Saudi retail pharmacy to publish diabetes results at this important platform, which is one of the leading journals publishing health services research in the context of pharmacy, pharmaceutical care, medicines and medicines management. The IJPP targets academics, practitioners in healthcare,"...

Continue Reading >

Galderma Advances Phase 3 Clinical Study with Nemolizumab in Moderate-to-Severe Atopic Dermatitis
October 10, 2019

Galderma, a global leader focused on meeting the world's increasing skin health needs, announced that it has enrolled the first patients in a new Phase 3 clinical study with nemolizumab, an investigational therapy in adult patients with moderate-to-severe atopic dermatitis.

This study is a randomized, double-blinded, placebo-controlled study to assess the efficacy and safety of nemolizumab"...

Continue Reading >